| John W Marshall, MD | |
|
201 Ridge St, Suite 202, Council Bluffs, IA 51503-4643 | |
| (712) 325-0022 | |
| (712) 325-8102 |
| Full Name | John W Marshall |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 201 Ridge St, Council Bluffs, Iowa |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003989187 | NPI | - | NPPES |
| 20278 | Other | COVENTRY | |
| 0166561 | Medicaid | IA | |
| 0400056 | Other | UNITED HEALTH CARE | |
| 16656 | Other | IA | WELLMARK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 20313 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| John W Marshall, MD 201 Ridge St, Suite 202, Council Bluffs, IA 51503-4643 Ph: (712) 325-0022 | John W Marshall, MD 201 Ridge St, Suite 202, Council Bluffs, IA 51503-4643 Ph: (712) 325-0022 |
News Archive
The novel oral drug venetoclax can be safely added to standard therapies for some high-risk myeloid blood cancers and in early studies the combination shows promise of improved outcomes, say scientists from Dana-Farber Cancer Institute.
Scientists at A*STAR's Genome Institute of Singapore have discovered an unusual gene that controls the generation of neurons. This important finding, which is crucial in understanding serious diseases of the brain such as Alzheimer's disease, was reported in the 8th August 2013 issue of the prestigious scientific journal, Molecular Cell.
Ambit Biosciences, a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced the initiation of the Phase 2 cohort of the MD Anderson Cancer Center-sponsored Phase 1/2 study of quizartinib in combination with either 5-azacitidine or low dose cytarabine for previously untreated FLT3-ITD positive acute myeloid leukemia (AML) patients age 60 or older, or FLT3-ITD positive AML patients 18 years of age or older in first relapse.
Small measurement uncertainties in clinical laboratory tests can add large amounts to health care costs, according to a newly released study commissioned by the National Institute of Standards and Technology (NIST).
Researchers from UCLA's Jonsson Comprehensive Cancer Center have discovered a biological mechanism that allows brain tumor cells to escape from the drugs designed to target them, resulting in drug resistance. The study was published in the December 5, 2013 online issue of Science.
› Verified 3 days ago
Anand Deshmukh, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Edmundson Pl, Ste. #306, Council Bluffs, IA 51503 Phone: 712-396-7787 Fax: 712-396-4115 | |
Dr. Erica K. Cichowski, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 1702 N 16th St, Council Bluffs, IA 51501 Phone: 712-256-7223 Fax: 712-256-7669 | |
Dr. Vikrant Salaria, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 Mercy Dr, Suite 120, Council Bluffs, IA 51503 Phone: 712-388-2770 Fax: 712-388-2771 | |
Dr. Kevin Crowley, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Edmundson Pl, Suite 310, Council Bluffs, IA 51503 Phone: 712-396-4300 Fax: 712-396-7069 | |
Christopher J Holewinski, RP, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 Mercy Dr, Council Bluffs, IA 51503 Phone: 712-328-5490 Fax: 712-325-2499 | |
Dr. Kalpana Kumar Puri, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 201 Ridge St Ste 312, Council Bluffs, IA 51503 Phone: 712-322-5532 Fax: 712-309-0193 |